Fulcrum Therapeutics, Inc.

NASDAQ:FULC

3.49 (USD) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q4
Operating Activities:
Net Income 55.409-26.87-24.756-24.017-23.783-24.779-26.136-23.738-34.07-25.928-23.484-20.716-19.648-16.999-17.72-18.962-15.685-18.452-16.123-16.542-13.169-36.843-8.859-8.943-7.846-6.94
Depreciation & Amortization 0.40.4790.5080.5310.5670.5660.5910.6110.6760.5360.6210.6190.6720.6030.7330.5540.5530.5390.5190.5160.5140.5040.5090.4590.2030.174
Deferred Income Tax 00-5.23900000000000000000000000
Stock Based Compensation 4.3443.9163.4493.7373.3634.2533.2713.3532.8793.8473.7932.6582.5462.0731.6771.7762.2041.6931.2741.1790.950.8210.7620.5060.4620.429
Change In Working Capital -0.096-1.648-1.031-1.5720.78-2.793.179-8.222.861-0.914-3.174-5.226-1.512-1.977-4.55112.145-1.1521.0619.8351.83-0.3690.031.1853.8581.774-0.295
Accounts Receivables -2.3330.5370.0430.076-0.5570.130.0130.344-0.3572.5-2.5-0.511-0.1252-1.9390.163-0.43-0.32500000000
Change In Inventory 000-0.0760.5570000-2.24-0.35100-0.536000000000000
Change In Accounts Payables -0.2931.1-0.817-0.2870.1630.0880.903-2.55-0.0380.5091.176-0.825-0.2980.920.1830.1540.0071.429-2.0462.398-0.7821.233-0.152-0.3710.3070.196
Other Working Capital 2.53-3.285-0.257-1.2850.617-3.0082.263-6.014-1.288-1.683-1.85-4.401-1.214-4.897-4.73411.991-1.159-0.36811.881-0.5680.413-1.2031.3374.2291.467-0.491
Other Non Cash Items 6.6122.0763.911-1.585-1.712-1.366-0.6010.112-0.8890.3530.3860.0920.1210.0740.035-0.017-0.041-0.0457.9542.398-0.78225.591-0.152-0.3710.3070.196
Operating Cash Flow 58.899-25.284-23.158-22.906-20.785-24.116-19.696-27.882-27.366-22.106-21.858-22.573-17.821-16.226-19.826-4.504-14.121-15.204-4.495-13.017-12.074-9.897-6.403-4.12-5.407-6.632
Investing Activities:
Investments In Property Plant And Equipment 0-0.028-0.077-0.065-0.195-0.171-0.116-0.283-1.318-0.246-0.519-0.367-0.565-0.262-0.472-0.093-0.21-0.567-0.108-0.214-0.221-0.31-3.466-0.926-3.806-0.783
Acquisitions Net 00-18.43155.04674.06693.7736.2461.996000000000000000000
Purchases Of Investments -63.238-55.816-25.074-25.986-17.328-126.504-83.289-52.698-10.176-4.99-34.885-129.564-48.788-2.997-43-8.617-16.816-55.83700000000
Sales Maturities Of Investments 50.7393.97243.50545.07137.39832.73447.04350.70242.88924.89526.3123.29522.99915.67428.87422.816.8000000000
Other Investing Activites -12.50838.15618.431-55.046-74.066-93.77-36.246-1.99632.71319.905-8.575-106.269-25.78912.677-14.12614.183-0.016-55.837000-0.0910000
Investing Cash Flow -12.50838.12818.35419.0219.875-93.941-36.362-2.27931.39519.659-9.094-106.636-26.35412.415-14.59814.09-0.226-56.404-0.108-0.214-0.221-0.401-3.466-0.926-3.806-0.783
Financing Activities:
Debt Repayment 0000000000-0.001-0.001-0.005-0.013-0.013-0.013-0.012-0.012-0.011-0.013-0.01-0.011-0.011-0.01-0.007-0.042
Common Stock Issued 0.3771.6510.28700.142117.345-0.04980.8532.8110.348-0.077135.527-0.01747.4245.929-0.35100.286-0.2764.225000.012-0.01700.017
Common Stock Repurchased 00000000000000-0.193-0.0700-0.2700-0.034-0.006000
Dividends Paid 00000000000000000000000000
Other Financing Activities 0.3771.6510.287117.8350.1420.3480.2670.0932.8110.3480.9692.3750.2310.0930.5320.28164.6980.28663.9780.988-0.519-0.002-0.09179.85212.65712.665
Financing Cash Flow 0.3771.6510.287117.8350.142117.6930.21880.9462.8110.3480.891137.9030.20947.5046.255-0.08364.6860.274-0.28165.2-0.529-0.047-0.0979.82512.6512.64
Other Information:
Effect Of Forex Changes On Cash 00119.331-118.967-0.364000000000000000000000
Net Change In Cash 46.75314.386-4.517-3.886-0.768-0.364-55.8450.7856.84-2.099-30.0618.694-43.96643.693-28.1699.50350.339-71.334-4.88451.969-12.824-10.345-9.95974.7793.4375.225
Cash At End Of Period 86.70239.94925.56331.17235.05835.82636.1992.0341.24534.40536.50466.56557.871101.83758.14486.31376.8126.47197.805102.68950.7263.54473.88983.8489.0695.632